3505 results for «34»

Filter By

3505 results

Mitral - Late-Breaking Trials and Innovations

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!

Mitral - Late-Breaking

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

29 Nov 2022 – From PCR London Valves 2022

Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

Valve-in-valve TAVI: Session 2

28 Nov 2022 – From PCR London Valves 2022

Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...

Valve-in-valve TAVI: Session 2

Rapid-fire abstracts: Session 11

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!

Rapid-fire abstracts: Session 11

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

Rapid-fire clinical cases: Session 4

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...

Rapid-fire clinical cases: Session 4

How to achieve safe early discharge

29 Nov 2022 – From PCR London Valves 2022

Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!

How to achieve safe early discharge

TAVI in patients at risk of coronary occlusion

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...

TAVI in patients at risk of coronary occlusion

Mitral: new devices and procedural refinements

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!

Mitral: new devices and procedural refinements

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Mitral complications

28 Nov 2022 – From PCR London Valves 2022

Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.

Mitral complications

Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case

29 Nov 2022 – From PCR London Valves 2022

Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:

  1. LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
    The operators...
Mitral edge-to-edge repair: surgical and transcatheter approaches

Aortic stenosis and concomitant mitral valve disease

29 Nov 2022 – From PCR London Valves 2022

Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.

Aortic stenosis and concomitant mitral valve disease

Mitral annular calcification - From diagnosis to treatment

29 Nov 2022 – From PCR London Valves 2022

Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.

Mitral annular calcification - From diagnosis to treatment

Imaging for tricuspid valve interventions

29 Nov 2022 – From PCR London Valves 2022

Among the abstracts proposed in this PCR LV 2022 session, discover echocardiographic predictors of effective edge-to-edge repair in TR, TR in patients with continuous right ventricular pacing, TR and severe left-sided valvular heart disease, and much more!

Imaging for tricuspid valve interventions

TAVI challenges: session 4

29 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.

TAVI challenges: session 4

Mitral edge-to-edge repair: challenging cases

Watch an acute papillary muscle rupture with torrential mitral regurgitation, a transcatheter mitral edge-to-edge repair in recurrent mitral regurgitation after Alfieri stitch, and several other exciting challenging cases in this PCR LV 2022 session!

Mitral edge-to-edge repair: challenging cases

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2
Didn’t find what you were looking for?